Kenneth Heatwole
Family Medicine · Mechanicsville, VANPI 1568435048
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.6% of the total across 256 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 15.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,126 and has fallen 55.3% since, to $504 in 2022.
Across 256 payments — averaging $14.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$593
- AstraZeneca$455
- Amarin Pharma, Inc.$265
- Amgen$262
- AbbVie$261
- Pfizer$251
- plus $2K from 28 others
What the payments were for
- Food & beverage$3,767100%
- Education$160%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 49 | $593 |
| AstraZeneca | 15 | $455 |
| Amarin Pharma, Inc. | 18 | $265 |
| Amgen | 18 | $262 |
| AbbVie(2 entities) | 21 | $261 |
| Pfizer | 21 | $251 |
| Lilly USA, LLC | 14 | $211 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 13 | $211 |
| Johnson & Johnson | 10 | $125 |
| GSK | 10 | $119 |
| Sanofi-aventis U.S. LLC | 7 | $105 |
| Boehringer Ingelheim | 7 | $104 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $96 |
| Biohaven Pharmaceuticals, Inc. | 4 | $91 |
| Bayer | 4 | $85 |
| Esperion Therapeutics, Inc. | 5 | $79 |
| Teva Pharmaceuticals USA, Inc. | 4 | $64 |
| Genentech USA, Inc. | 4 | $55 |
| Amneal Pharmaceuticals LLC | 3 | $45 |
| Merck | 3 | $40 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| Abbott | 2 | $31 |
| Radius Health, Inc. | 2 | $26 |
| Novartis | 2 | $25 |
| Lundbeck LLC | 1 | $20 |
| AMAG Pharmaceuticals, Inc. | 1 | $16 |
| Edwards Lifesciences | 1 | $16 |
| Jazz Pharmaceuticals Inc. | 1 | $16 |
| Biogen | 1 | $15 |
| Agile Therapeutics, Inc. | 1 | $15 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $15 |
| Astellas Pharma US Inc | 1 | $14 |
| Shire North American Group Inc | 1 | $11 |
| Concordia Pharmaceuticals Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$102
How this compares
$3,783 in reported general payments places this provider in the 85th percentile of 2,553 family medicine providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metoprolol Succinate | 14 | $163 |
| Rosuvastatin Calcium | 13 | $73 |
| Losartan Potassium | 13 | $62 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Mechanicsville
- Oluwaronke AwosikaFort Gregg Adams$397K
- Monique MatuskowitzNorfolk$110K
- Paul StairsRichmond$105K
- Edwin RobinsonRichmond$83K
- Benjamin PhilpottRocky Mount$64K
- John MolaiyArlington$64K
- Catherine VarneyZion Crossroads$47K
- Jordan TranWinchester$42K
- John ClayColonial Heights$40K
- Thomas RobesonNewport News$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.